Oramed Pharmaceuticals (ORMP) News Today → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free ORMP Stock Alerts $2.46 +0.16 (+6.96%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShort Interest in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Declines By 37.0%marketbeat.com - April 27 at 11:34 PMBML Capital Management LLC Has $2.91 Million Stake in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)marketbeat.com - April 24 at 5:18 AMOramed Pharmaceuticals Inc. (NASDAQ:ORMP) Sees Large Growth in Short Interestmarketbeat.com - April 15 at 4:39 PMORMP Apr 2024 2.500 putfinance.yahoo.com - March 16 at 1:52 AMOramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - March 9 at 2:05 PMmarketbeat.com - March 6 at 9:36 AMRathbones Group PLC Acquires Shares of 289,803 Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)marketbeat.com - February 22 at 7:54 AMOramed to reinitiate pivotal type 2 diabetes trial after Phase III flopmsn.com - February 21 at 6:04 PMOramed Pharmaceuticals Inc.: Oramed Letter to Shareholdersfinanznachrichten.de - February 20 at 4:02 PMOramed Letter to Shareholdersprnewswire.com - February 20 at 8:30 AMORMP: Multiple Potential Applications for Proprietary Oral Protein Delivery Platformfinance.yahoo.com - January 24 at 1:21 PMOramed Pharmaceuticals (ORMP) Price Target Increased by 36.51% to 4.39msn.com - November 28 at 8:11 PMOramed Pharmaceuticals (ORMP) Price Target Increased by 57.50% to 3.21msn.com - November 2 at 10:07 AMOramed Pharmaceuticals (NASDAQ:ORMP) investors are sitting on a loss of 63% if they invested a year agofinance.yahoo.com - October 6 at 1:58 PMOramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Companyfinance.yahoo.com - September 21 at 7:02 PMCorsair Capital Management L.P. Makes New Investment in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)marketbeat.com - September 8 at 9:57 AMOramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globallyfinance.yahoo.com - August 2 at 11:08 AMOramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Down 15.1% in Julymarketbeat.com - July 28 at 3:12 AMOramed Pharmaceuticals, Inc.jp.reuters.com - July 25 at 12:37 PMETF Managers Group LLC Acquires Shares of 68,940 Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)marketbeat.com - July 3 at 5:15 AMOramed to Present at the 83rd American Diabetes Association Conferencefinance.yahoo.com - June 20 at 10:21 AMOramed Pharmaceuticals (NASDAQ:ORMP) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - June 17 at 2:50 PMCitigroup Inc. Has $793,000 Holdings in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)marketbeat.com - June 2 at 5:16 AMORMP: Advancing Development Efforts in Chinafinance.yahoo.com - May 30 at 8:46 PMRussell Investments Group Ltd. Makes New $680,000 Investment in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)marketbeat.com - May 28 at 4:21 AMOramed Pharmaceuticals Inc. (NASDAQ:ORMP) to Post Q2 2023 Earnings of ($0.09) Per Share, HC Wainwright Forecastsmarketbeat.com - May 26 at 5:44 AMH.C. Wainwright Sticks to Their Hold Rating for Oramed Pharm (ORMP)markets.businessinsider.com - May 24 at 6:43 AMCanaccord Genuity Maintains Oramed Pharmaceuticals (ORMP) Hold Recommendationmsn.com - May 18 at 8:41 AMOramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summitfinance.yahoo.com - May 18 at 8:41 AMOramed Pharmaceuticals (NASDAQ:ORMP) Receives New Coverage from Analysts at StockNews.commarketbeat.com - May 18 at 4:35 AMOramed Surges on New Diabetes Treatmentmsn.com - May 16 at 4:57 AMWhy Oramed Pharmaceuticals Shares Are Trading Higher Todaymsn.com - May 15 at 1:06 PMOramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in Chinafinance.yahoo.com - May 15 at 1:06 PMOramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Down 33.4% in Aprilmarketbeat.com - May 11 at 4:37 AMInvesting millions, Ben Shapiro joins board of Oramed Pharmaceuticalsmsn.com - May 3 at 7:26 AM8-K: ORAMED PHARMACEUTICALS INC.marketwatch.com - May 2 at 4:25 PMConservative Pundit Ben Shapiro Invests $4.7 Million in Israeli Drug Companyfinance.yahoo.com - May 2 at 4:25 PMOramed Appoints Ben Shapiro to its Board of Directorsfinance.yahoo.com - May 1 at 6:02 PMOramed Pharmaceuticals, Incmoney.usnews.com - April 5 at 8:12 AMThe past year for Oramed Pharmaceuticals (NASDAQ:ORMP) investors has not been profitablefinance.yahoo.com - March 27 at 7:56 AMOramed Pharmaceuticals Chief Scientific Officer Sold $200K In Company Stockbenzinga.com - March 16 at 2:25 PMDirector of Oramed Pharmaceuticals Makes $141K Buybenzinga.com - March 16 at 2:25 PMH.C. Wainwright Reaffirms Their Hold Rating on Oramed Pharm (ORMP)markets.businessinsider.com - March 13 at 10:48 AMOramed Pharmaceuticals Inc. (ORMP.TA)finance.yahoo.com - February 16 at 7:38 AMOramed Pharmaceuticals Issues Shareholder Updatefinance.yahoo.com - February 9 at 12:40 PMOramed Pharmaceuticals Inc. Expected to Post FY2023 Earnings of ($0.87) Per Share (NASDAQ:ORMP)marketbeat.com - January 27 at 7:13 AMORMP: ORA-D-013-1 Failed To Meet Endpoints; Ending T2D Oral Insulin Effortsfinance.yahoo.com - January 25 at 4:26 PMHot Stocks: CTSH rises on guidance; LOGI slumps; CAT hits 52-week high; ORMP plunges 76%seekingalpha.com - January 12 at 11:26 PMOramed Pharmaceuticals Shares Crumble as Diabetes Drug Fails >ORMPmarketwatch.com - January 12 at 1:25 PMWhy Oramed Pharmaceuticals Stock Is Crashing Todayfinance.yahoo.com - January 12 at 1:25 PM Get Oramed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORMP and its competitors with MarketBeat's FREE daily newsletter. Email Address This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work? Click Here To Get Your Free Copy ORMP Media Mentions By Week ORMP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORMP News Sentiment▼1.550.33▲Average Medical News Sentiment ORMP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORMP Articles This Week▼30▲ORMP Articles Average Week Get Oramed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORMP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Seres Therapeutics News Today Barinthus Biotherapeutics News Today Genelux News Today Connect Biopharma News Today Milestone Pharmaceuticals News Today Anixa Biosciences News Today Cartesian Therapeutics News Today IO Biotech News Today Reviva Pharmaceuticals News Today Emergent BioSolutions News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORMP) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
